http://orcid.org/0000-0001-5252-8710
References
- McGrouther DA. The microanatomy of Dupuytren's contracture. Hand. 1982;14(3):215–236.
- Luck JV. Dupuytren's contracture; a new concept of the pathogenesis correlated with surgical management. J Bone Joint Surg Am. 1959;41-A(4):635–664.
- Crean SM, Gerber RA, Le Graverand MPH, et al. The efficacy and safety of fasciectomy and fasciotomy for Dupuytren's contracture in European patients: a structured review of published studies. J Hand Surg Eur Vol. 2011;36(5):396–407.
- Badois FJ, et al. [Non-surgical treatment of Dupuytren disease using needle fasciotomy]. Rev Rhum Ed Fr. 1993;60(11):808–813.
- Lermusiaux JL, Lellouche H, Badois JF, et al. How should Dupuytren's contracture be managed in 1997? Rev Rhum Engl Ed. 1997;64(12):775–776.
- van Rijssen AL, Gerbrandy FSJ, Linden HT, et al. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study. J Hand Surg Am. 2006;31(5):717–725.
- van Rijssen AL, ter Linden H, Werker PM. Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy. Plast Reconstr Surg. 2012;129(2):469–477.
- Bainbridge C, Dahlin LB, Szczypa PP, et al. Current trends in the surgical management of Dupuytren's disease in Europe: an analysis of patient charts. Eur Orthop Traumatol. 2012;3(1):31–41.
- Atroshi I, Gummesson C, Andersson B, et al. The disabilities of the arm, shoulder and hand (DASH) outcome questionnaire: reliability and validity of the Swedish version evaluated in 176 patients. Acta Orthop Scand. 2000;71(6):613–618.
- McMillan C, Binhammer P. Steroid injection and needle aponeurotomy for Dupuytren disease: long-term follow-up of a randomized controlled trial. J Hand Surg Am. 2014;39(10):1942–1947.
- Pess GM, Pess RM, Pess RA. Results of needle aponeurotomy for Dupuytren contracture in over 1000 fingers. J Hand Surg Am. 2012;37(4):651–656.
- Werker PMN, Pess GM, van Rijssen AL, et al. Correction of contracture and recurrence rates of Dupuytren contracture following invasive treatment: the importance of clear definitions. J Hand Surg Am. 2012;37(10):2095–2105 e7.
- Krefter C, Marks M, Hensler S, et al. Complications after treating Dupuytren's disease. A systematic literature review. Hand Surg Rehabil. 2017;36(5):322–329.
- Ball C, Pratt AL, Nanchahal J. Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice. BMC Musculoskelet Disord. 2013;14(1):131.
- Stromberg J, Ibsen Sorensen A, Friden J. Percutaneous needle fasciotomy versus collagenase treatment for dupuytren contracture: a randomized controlled trial with a two-year follow-up. J Bone Joint Surg Am. 2018;100(13):1079–1086.
- Baltzer H, Binhammer PA. Cost-effectiveness in the management of Dupuytren's contracture. A Canadian cost-utility analysis of current and future management strategies. Bone Joint J. 2013;95-B(8):1094–1100.
- Soreide E, Murad MH, Denbeigh JM, et al. Treatment of Dupuytren's contracture. Bone Joint J. 2018;100-B(9):1138–1145.
- Scherman P, Jenmalm P, Dahlin LB. Three-year recurrence of Dupuytren's contracture after needle fasciotomy and collagenase injection: a two-centre randomized controlled trial. J Hand Surg Eur Vol. 2018;43(8):836–840.